Clinical Outcomes of Transarterial Embolization in the Treatment of Pulmonary Sequestration
Purpose To assess the safety and efficacy of transarterial embolization (TAE) for pulmonary sequestration (PS). Methods A single-center, retrospective study was conducted from March 2013 and December 2020. Patient characteristics, laboratory/imaging, complications, and the TAE procedure were reviewe...
Gespeichert in:
| Veröffentlicht in: | Cardiovascular and interventional radiology 2021-09, Vol.44 (9), p.1491-1496 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1496 |
|---|---|
| container_issue | 9 |
| container_start_page | 1491 |
| container_title | Cardiovascular and interventional radiology |
| container_volume | 44 |
| creator | Bi, Yonghua Li, Jindong Yi, Mengfei Ren, Jianzhuang Han, Xinwei |
| description | Purpose
To assess the safety and efficacy of transarterial embolization (TAE) for pulmonary sequestration (PS).
Methods
A single-center, retrospective study was conducted from March 2013 and December 2020. Patient characteristics, laboratory/imaging, complications, and the TAE procedure were reviewed.
Results
We report 11 symptomatic patients with PS successfully treated by TAE. The aberrant supplying arteries were embolized, and there were no immediate complications. One to three days after TAE, patients complained of mild chest pain (
n
= 4), moderate chest pain (
n
= 3), and low-grade fever (
n
= 1). Chest pain symptoms were completely resolved after 2–4 days. One patient with PS and bronchiectasis required thoracoscopic resection due to continued symptoms. The remaining 10 patients showed disappearance of chest pain and hemoptysis and decreased lesion size at 2 weeks and 3 months, with a clinical success rate of 90.9%.
Conclusions
TAE may be a feasible alternative treatment for pulmonary sequestration. |
| doi_str_mv | 10.1007/s00270-021-02885-3 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2541787458</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2541787458</sourcerecordid><originalsourceid>FETCH-LOGICAL-c352t-f32f5421339d89a582519c0ebbb5edddc850cc16575158ccd0605fb08b9945143</originalsourceid><addsrcrecordid>eNp9kE9LxDAQxYMouK5-AU8FL16qk6TTpkdZ1j-wsIIrCB5CmqbapU3WpD3opze7KwgePAxzmN-befMIOadwRQGK6wDACkiB0VhCYMoPyIRmnKUg8pdDMgFaZClFpMfkJIQ1AEXBcEJeZ11rW626ZDkO2vUmJK5JVl7ZoPxgfBsn875yXfulhtbZpLXJ8G4iYdTQGzts8cex651V_jN5Mh-jCYPfsafkqFFdMGc_fUqeb-er2X26WN49zG4WqebIhrThrMGMUc7LWpRq64uWGkxVVWjqutYCQWuaY4HRtNY15IBNBaIqywzjk1Nyud-78W53XvZt0KbrlDVuDJJhRgtRZCgievEHXbvR2-guUjnHXAAWkWJ7SnsXgjeN3Pi2j_9JCnKbt9znLWPecpe35FHE96IQYftm_O_qf1Tf8y-DFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2563568057</pqid></control><display><type>article</type><title>Clinical Outcomes of Transarterial Embolization in the Treatment of Pulmonary Sequestration</title><source>SpringerLink Journals - AutoHoldings</source><creator>Bi, Yonghua ; Li, Jindong ; Yi, Mengfei ; Ren, Jianzhuang ; Han, Xinwei</creator><creatorcontrib>Bi, Yonghua ; Li, Jindong ; Yi, Mengfei ; Ren, Jianzhuang ; Han, Xinwei</creatorcontrib><description>Purpose
To assess the safety and efficacy of transarterial embolization (TAE) for pulmonary sequestration (PS).
Methods
A single-center, retrospective study was conducted from March 2013 and December 2020. Patient characteristics, laboratory/imaging, complications, and the TAE procedure were reviewed.
Results
We report 11 symptomatic patients with PS successfully treated by TAE. The aberrant supplying arteries were embolized, and there were no immediate complications. One to three days after TAE, patients complained of mild chest pain (
n
= 4), moderate chest pain (
n
= 3), and low-grade fever (
n
= 1). Chest pain symptoms were completely resolved after 2–4 days. One patient with PS and bronchiectasis required thoracoscopic resection due to continued symptoms. The remaining 10 patients showed disappearance of chest pain and hemoptysis and decreased lesion size at 2 weeks and 3 months, with a clinical success rate of 90.9%.
Conclusions
TAE may be a feasible alternative treatment for pulmonary sequestration.</description><identifier>ISSN: 0174-1551</identifier><identifier>EISSN: 1432-086X</identifier><identifier>DOI: 10.1007/s00270-021-02885-3</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Arteries ; Bronchiectasis ; Cardiology ; Chest ; Clinical outcomes ; Complications ; Embolisation (arterial) ; Embolization ; Fever ; Hemoptysis ; Imaging ; Medicine ; Medicine & Public Health ; Nuclear Medicine ; Pain ; Patients ; Radiology ; Short Communication ; Ultrasound</subject><ispartof>Cardiovascular and interventional radiology, 2021-09, Vol.44 (9), p.1491-1496</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2021</rights><rights>Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c352t-f32f5421339d89a582519c0ebbb5edddc850cc16575158ccd0605fb08b9945143</citedby><cites>FETCH-LOGICAL-c352t-f32f5421339d89a582519c0ebbb5edddc850cc16575158ccd0605fb08b9945143</cites><orcidid>0000-0002-8411-6427</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00270-021-02885-3$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00270-021-02885-3$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids></links><search><creatorcontrib>Bi, Yonghua</creatorcontrib><creatorcontrib>Li, Jindong</creatorcontrib><creatorcontrib>Yi, Mengfei</creatorcontrib><creatorcontrib>Ren, Jianzhuang</creatorcontrib><creatorcontrib>Han, Xinwei</creatorcontrib><title>Clinical Outcomes of Transarterial Embolization in the Treatment of Pulmonary Sequestration</title><title>Cardiovascular and interventional radiology</title><addtitle>Cardiovasc Intervent Radiol</addtitle><description>Purpose
To assess the safety and efficacy of transarterial embolization (TAE) for pulmonary sequestration (PS).
Methods
A single-center, retrospective study was conducted from March 2013 and December 2020. Patient characteristics, laboratory/imaging, complications, and the TAE procedure were reviewed.
Results
We report 11 symptomatic patients with PS successfully treated by TAE. The aberrant supplying arteries were embolized, and there were no immediate complications. One to three days after TAE, patients complained of mild chest pain (
n
= 4), moderate chest pain (
n
= 3), and low-grade fever (
n
= 1). Chest pain symptoms were completely resolved after 2–4 days. One patient with PS and bronchiectasis required thoracoscopic resection due to continued symptoms. The remaining 10 patients showed disappearance of chest pain and hemoptysis and decreased lesion size at 2 weeks and 3 months, with a clinical success rate of 90.9%.
Conclusions
TAE may be a feasible alternative treatment for pulmonary sequestration.</description><subject>Arteries</subject><subject>Bronchiectasis</subject><subject>Cardiology</subject><subject>Chest</subject><subject>Clinical outcomes</subject><subject>Complications</subject><subject>Embolisation (arterial)</subject><subject>Embolization</subject><subject>Fever</subject><subject>Hemoptysis</subject><subject>Imaging</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nuclear Medicine</subject><subject>Pain</subject><subject>Patients</subject><subject>Radiology</subject><subject>Short Communication</subject><subject>Ultrasound</subject><issn>0174-1551</issn><issn>1432-086X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kE9LxDAQxYMouK5-AU8FL16qk6TTpkdZ1j-wsIIrCB5CmqbapU3WpD3opze7KwgePAxzmN-befMIOadwRQGK6wDACkiB0VhCYMoPyIRmnKUg8pdDMgFaZClFpMfkJIQ1AEXBcEJeZ11rW626ZDkO2vUmJK5JVl7ZoPxgfBsn875yXfulhtbZpLXJ8G4iYdTQGzts8cex651V_jN5Mh-jCYPfsafkqFFdMGc_fUqeb-er2X26WN49zG4WqebIhrThrMGMUc7LWpRq64uWGkxVVWjqutYCQWuaY4HRtNY15IBNBaIqywzjk1Nyud-78W53XvZt0KbrlDVuDJJhRgtRZCgievEHXbvR2-guUjnHXAAWkWJ7SnsXgjeN3Pi2j_9JCnKbt9znLWPecpe35FHE96IQYftm_O_qf1Tf8y-DFA</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Bi, Yonghua</creator><creator>Li, Jindong</creator><creator>Yi, Mengfei</creator><creator>Ren, Jianzhuang</creator><creator>Han, Xinwei</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8411-6427</orcidid></search><sort><creationdate>20210901</creationdate><title>Clinical Outcomes of Transarterial Embolization in the Treatment of Pulmonary Sequestration</title><author>Bi, Yonghua ; Li, Jindong ; Yi, Mengfei ; Ren, Jianzhuang ; Han, Xinwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c352t-f32f5421339d89a582519c0ebbb5edddc850cc16575158ccd0605fb08b9945143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Arteries</topic><topic>Bronchiectasis</topic><topic>Cardiology</topic><topic>Chest</topic><topic>Clinical outcomes</topic><topic>Complications</topic><topic>Embolisation (arterial)</topic><topic>Embolization</topic><topic>Fever</topic><topic>Hemoptysis</topic><topic>Imaging</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nuclear Medicine</topic><topic>Pain</topic><topic>Patients</topic><topic>Radiology</topic><topic>Short Communication</topic><topic>Ultrasound</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bi, Yonghua</creatorcontrib><creatorcontrib>Li, Jindong</creatorcontrib><creatorcontrib>Yi, Mengfei</creatorcontrib><creatorcontrib>Ren, Jianzhuang</creatorcontrib><creatorcontrib>Han, Xinwei</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Cardiovascular and interventional radiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bi, Yonghua</au><au>Li, Jindong</au><au>Yi, Mengfei</au><au>Ren, Jianzhuang</au><au>Han, Xinwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical Outcomes of Transarterial Embolization in the Treatment of Pulmonary Sequestration</atitle><jtitle>Cardiovascular and interventional radiology</jtitle><stitle>Cardiovasc Intervent Radiol</stitle><date>2021-09-01</date><risdate>2021</risdate><volume>44</volume><issue>9</issue><spage>1491</spage><epage>1496</epage><pages>1491-1496</pages><issn>0174-1551</issn><eissn>1432-086X</eissn><abstract>Purpose
To assess the safety and efficacy of transarterial embolization (TAE) for pulmonary sequestration (PS).
Methods
A single-center, retrospective study was conducted from March 2013 and December 2020. Patient characteristics, laboratory/imaging, complications, and the TAE procedure were reviewed.
Results
We report 11 symptomatic patients with PS successfully treated by TAE. The aberrant supplying arteries were embolized, and there were no immediate complications. One to three days after TAE, patients complained of mild chest pain (
n
= 4), moderate chest pain (
n
= 3), and low-grade fever (
n
= 1). Chest pain symptoms were completely resolved after 2–4 days. One patient with PS and bronchiectasis required thoracoscopic resection due to continued symptoms. The remaining 10 patients showed disappearance of chest pain and hemoptysis and decreased lesion size at 2 weeks and 3 months, with a clinical success rate of 90.9%.
Conclusions
TAE may be a feasible alternative treatment for pulmonary sequestration.</abstract><cop>New York</cop><pub>Springer US</pub><doi>10.1007/s00270-021-02885-3</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-8411-6427</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0174-1551 |
| ispartof | Cardiovascular and interventional radiology, 2021-09, Vol.44 (9), p.1491-1496 |
| issn | 0174-1551 1432-086X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2541787458 |
| source | SpringerLink Journals - AutoHoldings |
| subjects | Arteries Bronchiectasis Cardiology Chest Clinical outcomes Complications Embolisation (arterial) Embolization Fever Hemoptysis Imaging Medicine Medicine & Public Health Nuclear Medicine Pain Patients Radiology Short Communication Ultrasound |
| title | Clinical Outcomes of Transarterial Embolization in the Treatment of Pulmonary Sequestration |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T03%3A45%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20Outcomes%20of%20Transarterial%20Embolization%20in%20the%20Treatment%20of%20Pulmonary%20Sequestration&rft.jtitle=Cardiovascular%20and%20interventional%20radiology&rft.au=Bi,%20Yonghua&rft.date=2021-09-01&rft.volume=44&rft.issue=9&rft.spage=1491&rft.epage=1496&rft.pages=1491-1496&rft.issn=0174-1551&rft.eissn=1432-086X&rft_id=info:doi/10.1007/s00270-021-02885-3&rft_dat=%3Cproquest_cross%3E2541787458%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2563568057&rft_id=info:pmid/&rfr_iscdi=true |